India’s Sun Pharmaceutical Industries agrees to buy the women’s health company for $14 a share in an all-cash deal.
The Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorisation to Biogen for a ...
Biogen Inc. (NASDAQ:BIIB) is one of the best stem cell therapy stocks to buy. On April 22, Biogen Inc. (NASDAQ:BIIB) was upgraded to Buy from Neutral by UBS, with the firm adjusting the price target ...
North Longford woman Kiara Lynch recently met with local TD Micheál Carrigy to discuss her campaign calling on the HSE to ...
The EMA’s CHMP has stated its positive opinions on three drugs for autoimmune, muscle wasting and rare genetic diseases.
Biogen heads into Q1 earnings with new drugs like Skyclarys and Zurzuvae driving growth as legacy MS products face rising competitive pressure.
Detailed price information for Coherus Oncology Inc (CHRS-Q) from The Globe and Mail including charting and trades.
Detailed price information for Definium Therapeutics Inc (DFTX-Q) from The Globe and Mail including charting and trades.
North Longford woman Kiara Lynch recently met with local TD Micheál Carrigy to discuss her campaign calling on the HSE to ...
Biogen Inc. (NASDAQ:BIIB) was among Jim Cramer’s stock calls on Mad Money recently. Toward the end of the lightning round, a ...
While Big Pharmas embarked on a frenzy of acquisitions over recent weeks, Roche’s CEO has explained to Fierce Biotech why the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results